Strategic evolution and partnering in the Indian pharmaceutical industry

被引：0

作者：

Sarathy, Ravi ^{[1
]}

机构：

[1] Northeastern Univ, Coll Business Adm, Boston, MA USA

来源：

EMERGING ECONOMIES AND THE TRANSFORMATION OF INTERNATIONAL BUSINESS: BRAZIL, RUSSIA, INDIA AND CHINA (BRICS) | 2006年

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：229 / 249

页数：21

共 11 条

[1]

*ERNST YOUNG, 2004, PROGR GLOB PHARM REP

[2] A resource perspective of global dynamic capabilities [J].

Griffith, DA ;

Harvey, MG .

JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2001, 32 (03) :597-606

[3] Exploiting technological opportunities: the timing of collaborations [J].

Katila, R ;

Mang, PY .

RESEARCH POLICY, 2003, 32 (02) :317-332

[4]

KHANNA T, 2005, 9703431 IIBS

[5] Innovation, organizational capabilities, and the born-global firm [J].

Knight, GA ;

Cavusgil, ST .

JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2004, 35 (02) :124-141

[6]

LINDER JC, 2004, DRUG IND ALLIANCE AR

[7] The international biotechnology industry: A dynamic capabilities perspective [J].

Madhok, A ;

Osegowitsch, T .

JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2000, 31 (02) :325-335

[8] Strategic alliance-based global sourcing strategy for competitive advantage: A conceptual framework and research propositions [J].

Murray, JY .

JOURNAL OF INTERNATIONAL MARKETING, 2001, 9 (04) :30-58

[9]

PADDISON C, 2004, AT KEARNEY EXECUTIVE, V7

[10] Technology sourcing through acquisitions: evidence from the US drug industry [J].

Ruckman, K .

JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2005, 36 (01) :89-103

← 1 2 →